Literature DB >> 10681427

The bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization.

R S Smith1, S W John, A Zabeleta, M T Davisson, N L Hawes, B Chang.   

Abstract

Ocular neovascularization is the leading cause of blindness in developed countries and often causes rapid loss of vision in age-related macular degeneration. Acute visual loss is most often due to hemorrhage from new vessels that have extended from the choroid into the subretinal space. Growth of abnormal vessels beneath the retina in this condition is known as subretinal neovascularization (SRN). Age-related animal models of macular degeneration and SRN have not been described. Current animal models of SRN depend on chemical or physical stimuli to initiate growth of subretinal vessels. The genes responsible for age-related human macular degeneration with SRN have not been firmly identified. We report an angiogenic phenotype in Bst/+ mice that is age-related, clinically evident, and resembles human SRN. This represents a spontaneous, genetically determined model of SRN. Bst/+ mice offer the possibility of exploring the molecular mechanisms of SRN without the need for exogenous agents.

Entities:  

Mesh:

Year:  2000        PMID: 10681427      PMCID: PMC15776          DOI: 10.1073/pnas.040531597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Long-term visual outcome in patients with optic nerve pit and serous retinal detachment of the macula.

Authors:  W M Sobol; C F Blodi; J C Folk; T A Weingeist
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

2.  Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity.

Authors:  D R Guyer; S L Fine; M G Maguire; B S Hawkins; S L Owens; R P Murphy
Journal:  Arch Ophthalmol       Date:  1986-05

3.  The optic fissure in the normal and microphthalmic mouse.

Authors:  I Hero
Journal:  Exp Eye Res       Date:  1989-08       Impact factor: 3.467

4.  The spectrum of cavitary optic disc anomalies in a family.

Authors:  M M Slusher; R G Weaver; C M Greven; T K Mundorf; L F Cashwell
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

5.  Phenotypic characterization and genetic analysis of twenty dominant cataract mutations detected in offspring of irradiated male mice.

Authors:  J Kratochvilova; J Favor
Journal:  Genet Res       Date:  1988-10       Impact factor: 1.588

6.  Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes.

Authors:  N L Hawes; R S Smith; B Chang; M Davisson; J R Heckenlively; S W John
Journal:  Mol Vis       Date:  1999-09-15       Impact factor: 2.367

7.  Biochemical evidence for conversion to milder form of hereditary mouse cataract by different genetic background.

Authors:  E Wada; H Koyama-Ito; A Matsuzawa
Journal:  Exp Eye Res       Date:  1991-05       Impact factor: 3.467

8.  Spectrum of optic nerve hypoplasia.

Authors:  L Frisén; L Holmegaard
Journal:  Br J Ophthalmol       Date:  1978-01       Impact factor: 4.638

9.  The prenatal development of the optic fissure in colobomatous microphthalmia.

Authors:  I Hero; M Farjah; C L Scholtz
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-08       Impact factor: 4.799

10.  Evidence for allelism of the recessive insertional mutation add and the dominant mouse mutation extra-toes (Xt).

Authors:  T M Pohl; M G Mattei; U Rüther
Journal:  Development       Date:  1990-12       Impact factor: 6.868

View more
  9 in total

1.  A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap.

Authors:  Jingtai Cao; Lian Zhao; Yiwen Li; Yang Liu; Weihong Xiao; Ying Song; Lingyu Luo; Deqiang Huang; George D Yancopoulos; Stanley J Wiegand; Rong Wen
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

Review 2.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

3.  Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma.

Authors:  Ran Wei; Xiang Ren; Hongyu Kong; Zhongping Lv; Yongjiang Chen; Yunjing Tang; Yujiao Wang; Lirong Xiao; Tao Yu; Sabiha Hacibekiroglu; Chen Liang; Andras Nagy; Rod Bremner; Danian Chen
Journal:  JCI Insight       Date:  2019-11-14

Review 4.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

Review 5.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Retinal neovascularization induced by mutant Vldlr gene inhibited in an inherited retinitis pigmentosa mouse model: an in-vivo study.

Authors:  Wei-Ming Yan; Pan Long; Mei-Zhu Chen; Dong-Yu Wei; Jian-Cong Wang; Zuo-Ming Zhang; Lei Zhang; Tao Chen
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

7.  Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute.

Authors:  Edward R Oliver; Thomas L Saunders; Susan A Tarlé; Tom Glaser
Journal:  Development       Date:  2004-08       Impact factor: 6.868

8.  Phenotypic and functional characterization of Bst+/- mouse retina.

Authors:  Hamidreza Riazifar; Guoli Sun; Xinjian Wang; Alan Rupp; Shruti Vemaraju; Fred N Ross-Cisneros; Richard A Lang; Alfredo A Sadun; Samer Hattar; Min-Xin Guan; Taosheng Huang
Journal:  Dis Model Mech       Date:  2015-05-08       Impact factor: 5.758

9.  Gene structure and chromosomal localization of mouse Opa1 : its exclusion from the Bst locus.

Authors:  Cécile Delettre; Guy Lenaers; Pascale Belenguer; Christian P Hamel
Journal:  BMC Genet       Date:  2003-05-07       Impact factor: 2.797

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.